Course Provider
One of Europe's foremost centres for psychedelic-assisted therapy, operating within Switzerland's compassionate use framework. Under Professor Daniele Zullino, HUG treats depression and PTSD with psilocybin, LSD, and MDMA, and hosts one of five university-affiliated psychedelic research laboratories in Switzerland.
Geneva University Hospital sits in the serious, clinically conservative end of psychedelic work rather than the commercial training market. Its strength is institutional credibility, specialist psychiatric lineage, and direct involvement in regulated patient care under Pr Daniele Zullino, which makes it most relevant for clinicians and researchers who want a grounded view of psychedelic-assisted psychotherapy in a hospital setting. It does not present as a broad public-facing school; it is a specialist academic provider embedded in addiction psychiatry and postgraduate medical teaching.
Best suited to licensed clinicians, psychiatric trainees, psychologists, nurses, and other health professionals working with addiction, depression, anxiety, PTSD, or complex mental health. It also suits researchers and advanced practitioners who want exposure to a hospital-based, regulation-aware model rather than a standalone certificate course.
HUG’s psychedelic work is framed as treatment within an existing therapeutic relationship, so patients must already be in follow-up care. For training, the publicly documented HUG education offer is professional and postgraduate in nature, aimed at health professionals; the psychedelic-specific pages do not publish a separate open-access prerequisite list.
HUG’s addiction service states that its continuing education activities include courses recognised by professional bodies, with a published example receiving SSPP and AMGe recognition for 1.5 hours. HUG also describes its department as part of the University of Geneva hospital-university framework and its psychiatry service as a recognised postgraduate training site, but it does not publish a standalone psychedelic-training accreditation or certification on the psychedelic service page.
HUG does not publish a single course tuition for psychedelic training because the psychedelic service is presented as clinical care rather than a fee-based course catalogue. Published patient-facing treatment costs are shown per medicine, with LSD, psilocybine and MDMA listed as variable range prices depending on the dose and clinical situation; these are treatment charges, not training fees.
Learners can expect a hospital-based understanding of psychedelic-assisted psychotherapy, including its legal framework, patient selection, and clinical positioning alongside existing psychotherapy. The broader HUG teaching offer points towards postgraduate competence-building rather than a portable branded certification.
Linked Courses
1
Active Listings
0
Primary Formats
Live Classes
Programs linked directly to this provider in the Blossom course dataset.
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.